More Chimeric Therapeutics Limited news Chimeric Therapeutics LimitedASX: CHM CHM cdh17 advances to dose level 2 May 21, 2025 at 3:59 AM UTC As issuedPlain English Chimeric Therapeutics Ltd has released a press release. View Attachment
